Steven P. Gelone - 06 Jan 2022 Form 4 Insider Report for Nabriva Therapeutics plc

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
N/A
Transactions as of
06 Jan 2022
Net transactions value
-$63.8
Form type
4
Filing time
10 Jan 2022, 15:18:43 UTC
Previous filing
04 Jan 2022
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability $63.8 -110 -0.03% $0.5800 366,023 06 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.